SULLIVAN GREGORY M
SEC insider (Form 3/4/5 filer). CIK 0001610106. Chief Medical Officer at Tonix Pharmaceuticals Holding Corp. (TNXP). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 24, 2026. Located in BERKLEY HEIGHTS, NJ.
Companies SULLIVAN GREGORY M has filed insider reports for
- Tonix Pharmaceuticals Holding Corp. (TNXP): Officer, Chief Medical Officer
SULLIVAN GREGORY M
CIK: 0001610106
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tonix Pharmaceuticals Holding Corp.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 24, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
39K shares- - Feb 24, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
39K shares- - Feb 25, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
29K shares- - Feb 25, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
29K shares- - Feb 5, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
OtherDirect0 shares at avg. $1.47$0.162
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 39,012 | - | - | Direct |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 39,011 | - | - | Direct |
| Feb 25, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 29,017 | - | - | Direct |
| Feb 25, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 29,017 | - | - | Direct |
| Feb 5, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Other | 0 | $1.47 | $0 | Direct |
1-5 of 5 transactions